Brought to you by 
Cell death companies Idun and Apoptech merge
09 Mar 2005
Executive Summary
Idun Pharmaceuticals and Apoptech, both developing technologies for apoptosis, programmable cell death, have merged in a stock swap that gives Apoptech a 20% interest in the combined company called Idun Pharmaceuticals Inc.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Cell death companies Idun and Apoptech merge
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice